al-Orainey I O, Gad el Rab M O, al-Hajjaj M S, Saeed E S
Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):58-61. doi: 10.1007/BF01971274.
An enzyme immunoassay (EIA) for the detection of mycobacterial antigens in sputum was evaluated. The system utilises commercially available anti-BCG immunoglobulin. BCG protein standard was used as positive control. Thirty-nine patients with culture-proven pulmonary tuberculosis were tested. The EIA was positive in 24 of 29 patients with positive smears and cultures, giving a sensitivity of 86.2%. It was also positive in six of ten patients with smear-negative culture-positive disease, resulting in a sensitivity of 60% in this group. In another 176 patients with different nontuberculous pulmonary infections, only nine were positive by EIA, giving a specificity of 94.9%. The high sensitivity and specificity of the assay make it a useful tool for the early diagnosis of pulmonary tuberculosis.
对一种用于检测痰液中分枝杆菌抗原的酶免疫测定法(EIA)进行了评估。该系统使用市售的抗卡介苗免疫球蛋白。卡介苗蛋白标准品用作阳性对照。对39例经培养证实为肺结核的患者进行了检测。在29例涂片和培养均为阳性的患者中,有24例EIA呈阳性,灵敏度为86.2%。在10例涂片阴性但培养阳性的患者中,有6例EIA也呈阳性,该组灵敏度为60%。在另外176例患有不同非结核性肺部感染的患者中,只有9例EIA呈阳性,特异性为94.9%。该检测方法的高灵敏度和特异性使其成为早期诊断肺结核的有用工具。